Status:
RECRUITING
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Friends of Prentice
Senior Faculty Academy
Conditions:
Hypertension in Pregnancy
Pre-Eclampsia
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
Detailed Description
The purpose of this research is to test the effect of two digital health interventions on cardiovascular health and subclinical cardiac dysfunction in postpartum individuals after pregnancies complica...
Eligibility Criteria
Inclusion
- Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital)
- Live birth at any gestational age
- Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension)
Exclusion
- HELLP syndrome
- History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease)
- Current Omron remote patient monitoring or Noom user
- BMI\<18.5 kg/m2 at enrollment
- Inadequate gestational weight gain or gestational weight loss
Key Trial Info
Start Date :
November 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06523569
Start Date
November 7 2024
End Date
June 30 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University, Dept. of Cardiology
Chicago, Illinois, United States, 60611